Mark Raffeld

7PUBLICATIONS
166CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2025
Immunotherapy Resistance in Lethal Prepubescent Spitz Melanoma With TERT Promoter Variant.

Alissa Groisser, Liny John, A Yasmine Kirkorian

|Jul 16, 2025
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy.

Robert J Kreitman, Brett Schroeder, Evgeny Arons

|Jun 04, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial.

Linda K Zane, Laura M Yee, Ting-Chia Chang

|Apr 07, 2025
Spatial Analysis of Hereditary Diffuse Gastric Cancer Reveals Indolent Phenotype of Signet Ring Cell Precursors.

Amber F Gallanis, Lauren A Gamble, Cihan Oguz

|Nov 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.

Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero

|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Melissa L Abel, Nobuyuki Takahashi, Cody Peer

Pageof 2

Frequent Collaborators

6 joint publications

Liqiang Xi

3 joint publications

Kenneth D Aldape

2 joint publications

Jung Kim

2 joint publications

James V Tricoli